Press release
Segment Overview and Primary Growth Areas in the Immunoglobulins Market
Immunoglobulins
Projected Market Size and Growth Trajectory of the Immunoglobulins Market
The immunoglobulins market is anticipated to grow rapidly, reaching a valuation of $30.89 billion by 2029. This expansion is expected to occur at a compound annual growth rate (CAGR) of 11.0%. Factors contributing to this robust growth include increasing investments aimed at developing advanced technologies, heightened awareness among healthcare professionals regarding immunodeficiency therapies, a rising preference for these treatments, the expansion of emerging markets, and growing applications in the fields of sports and fitness. Key trends identified for the forecast period encompass the rise of wearable and smart compression devices, the customization of compression therapy, integration of compression therapy into wound care, a strong focus on patient comfort and adherence, and collaborative efforts between manufacturers and healthcare providers to boost patient outcomes.
Download a free sample of the immunoglobulins market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3423&type=smp
Leading Companies Steering the Immunoglobulins Market Forward
Several prominent organizations currently hold significant stakes in the immunoglobulins sector. These industry leaders include Baxter International Inc., CSL Behring LLC, Grifols S. A., Octapharma AG, China Biologic Products Holdings Inc., Kedrion SpA, LFB SA, Biotest AG, Sanquin Blood Supply Foundation, ADMA Biologics Inc., Option Care Health Inc., Shanghai RAAS Blood Products Co. Ltd., Antibody Solutions, Bio Products Laboratory Ltd., Immunovant Inc., Kamada Ltd., Emergent BioSolutions Inc., Fresenius Kabi AG, GlaxoSmithKline plc, Pfizer Inc., Roche Holding AG, Samsung Bioepis Co. Ltd., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., and Zydus Cadila Healthcare Limited.
Strategic Acquisitions Strengthening Market Presence
In October 2022, the US-based pharmaceutical giant AbbVie Inc. acquired UK firm DJS Antibodies Ltd. for an undisclosed sum. This acquisition is expected to enhance AbbVie's antibody research capabilities, expand its immunology portfolio, and establish a strong foothold in Oxford's thriving bioscience hub. DJS Antibodies Ltd. specializes in antibody therapeutics, and this move aligns with AbbVie's ambitions to advance its research and development efforts in the immunoglobulin space.
View the full immunoglobulins market report:
https://www.thebusinessresearchcompany.com/report/biosimilar-therapeutic-peptide-global-market-report
Innovations and Product Launches Shaping the Immunoglobulins Market
Companies in the immunoglobulins market are focusing on launching innovative products to reach broader customer bases, increase sales, and boost revenue. For example, in September 2024, South Korean biotech firm GC Biopharma introduced ALYGLOTM (Immune Globulin Intravenous, Human-stwk) 10% Liquid into the US market. This product targets the treatment of primary humoral immunodeficiency (PI) in adults aged 17 and above and is available through specialty pharmacies. Given that the US represents the largest immunoglobulin market globally, valued at around $11.6 billion, GC Biopharma aims to generate $50 million in sales for ALYGLO during its first year, with plans to reach $300 million by 2028. Their growth strategy is supported by partnerships with key US pharmacy benefit managers and specialty pharmacies, which are essential for efficient distribution of immunoglobulin therapies.
Distinct Segments within the Immunoglobulins Market
This report categorizes the immunoglobulins market into several key segments for detailed analysis:
1) By Product Type: IGG, IGA, IGM, IGE, IGD
2) By Mode of Delivery: Intravenous and Subcutaneous
3) By Application Area: Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Immunodeficiency Disease, Myasthenia Gravis, Idiopathic Thrombocytopenic Purpura (ITP), and other uses.
Further subcategories provide deeper insights, such as:
- IGG segmented into IVIG (Intravenous Immunoglobulin) and SCIG (Subcutaneous Immunoglobulin)
- IGA split into Monoclonal and Polyvalent forms
- IGM divided into Monoclonal and Polyvalent types
- IGE categorized into Allergen-Specific and Monoclonal variants
- IGD classified between Research-Use and Monoclonal IGD
These specific product and application divisions help in understanding the detailed market landscape and opportunities across different immunoglobulin classes and delivery methods.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Segment Overview and Primary Growth Areas in the Immunoglobulins Market here
News-ID: 4318660 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Immunoglobulin
Immunoglobulin Market Forecast 2035 | Advancing Therapeutic Outcomes: Growth of …
An extensive study of propelling opportunities in, "Immunoglobulin Market Size, Share & Trends Analysis Report by Product Type (IgG, IgA, IgM, IgE, IgD), Form, Route of Administration, Application, Source, Technology, Therapy Type, Patient Demographics, End-user / Distribution Channel and Geography (North America, Europe, Asia Pacific, Middle East, Africa, and South America) - Global Industry Data, Trends, and Forecasts, 2025-2035" A comprehensive report of growing market landscapes in the immunoglobulin sector…
Rabies Immunoglobulin Market - Dynamics and Growth Pattern
The "Rabies Immunoglobulin Market" forecast 2031 report analyses the present and future competitive scenario of the analytics industry. Rabies Immunoglobulin Market report offers an in-depth analysis on segments including top companies, products, applications, revenue and regions. a number of topics including likewise market share, drivers, trends and methods. This report additionally offers insights into the latest growth and trends. It encapsulates key aspects of the market, with focus on leading…
Key Subcutaneous Immunoglobulin (SCIG) Market Trend for 2025-2034: Advancements …
What Is the Future Outlook for the Subcutaneous Immunoglobulin (SCIG) Market's Size and Growth Rate?
There has been a rapid expansion in the subcutaneous immunoglobulin (SCIG) market size in the previous years. It's projected to swell from $12.72 billion in 2024 to $14.52 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 14.1%. The upsurge in the past era is credited to the heightened occurrence of immunodeficiency disorders,…
Intravenous Immunoglobulin Market CAGR of intravenous immunoglobulin market is t …
The report is designed to provide a holistic view of the Intravenous Immunoglobulin Market .It provides the industry overview with market growth analysis with a historical & futuristic perspective for the following parameters; revenue, demands, and supply data (as applicable). Regional estimates and forecasts & trend analysis for eac country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Luxemburg, Rest of Europe, Japan, China, South…
Intravenous Immunoglobulin Market CAGR of intravenous immunoglobulin market is t …
The report is designed to provide a holistic view of the Intravenous Immunoglobulin Market . It provides the industry overview with market growth analysis with a historical & futuristic perspective for the following parameters; revenue, demands, and supply data (as applicable). Regional estimates and forecasts & trend analysis for eac country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Luxemburg, Rest of Europe, Japan, China,…
Immunoglobulin Market 2021 | Detailed Report
Global Immunoglobulin Market 2021-2027, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample PDF (including full TOC, Tables and Figures) of…
